# A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

> **NCT02934607** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 50 (actual)

## Conditions studied

- Study is Being Conducted in Healthy Volunteers

## Interventions

- **DRUG:** Symbicort pMDI with spacer device
- **DRUG:** Symbicort pMDI without spacer device

## Key facts

- **NCT ID:** NCT02934607
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-04
- **Primary completion:** 2017-03-27
- **Final completion:** 2017-03-27
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934607, "A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02934607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*